Skip to main content

Current Enzyme Inhibition aims to publish all the latest and outstanding developments in enzyme inhibition studies with regards to the mechanisms of inhibitory processes of enzymes, recognition of active sites, and the discovery of agonists and antagonists, leading to the design and development of new drugs of significant therapeutic value. Each issue contains a series of timely, in-depth reviews written by leaders in the field, covering a range of enzymes that can be exploited for drug development. Current Enzyme Inhibition is an essential journal for every pharmaceutical and medicinal chemist who wishes to have up-to-date knowledge about each and every development in the study of enzyme inhibition.

Publisher: Bentham Science Publishers

Volume 5, Number 1, February 2009

Articles

Colorectal Carcinogensis and Suppression of Tumor Development by Inhibition of Enzymes and Molecular Targets
pp. 1-26(26)
Authors: Yasui, Yumiko; Kim, Mihe; Oyama, Takeru; Tanaka, Takuji

Favourites:
ADD

Dopamine β-Monooxygenase: Mechanism, Substrates and Inhibitors
pp. 27-43(17)
Authors: Beliaev, Alexandre; Ferreira, Humberto; Learmonth, David A.; Soares-da-Silva, Patricio

Favourites:
ADD

The Role of 5'-AMP-Activated Protein Kinase (AMPK) in Diabetic Nephropathy: A New Direction?
pp. 44-50(7)
Authors: McMahon, K. W.; Zanescu, Dora I.; Sood, Vineeta; Beale, Elmus G.; Prabhakar, Sharma S.

Favourites:
ADD

The Biological Role of mTOR in the Pathogenesis of Solid Tumors: An Overview
pp. 51-65(15)
Authors: Koropouli, Eleftheria; Manolopoulos, Leonidas; Pandha, Hardev; Syrigos, Konstantinos N.

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more